Clinical Trial Update: Effects in The ApoB/ApoA-I Ratio Using Rosuvastatin and Atorvastatin in Patients With Acute Coronary Syndrome [Phase 3]

View source ↗

Summary

Phase 3 trial update assessing the effects of rosuvastatin and atorvastatin on the ApoB/ApoA-I ratio in patients with acute coronary syndrome; the study has com…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Coronary Syndrome

Drugs mentioned

• CRESTOR (Rosuvastatin)
• Lipitor (atorvastatin)

Snippet

Sponsor: AstraZeneca | Conditions: Acute Coronary Syndrome | Phase 3 | Status: COMPLETED